Location History:
- Washington, DC (US) (2007 - 2011)
- Shamong, NJ (US) (2018)
Company Filing History:
5 out of 58 
1 out of 13 
1 out of 832,761 Years Active: 2007-2018
Title: Michael S Spector: Innovator in Pharmaceuticals and Financial Products
Introduction
Michael S Spector is a notable inventor based in Washington, DC, with a focus on pharmaceutical formulations and financial products. He holds a total of 7 patents, showcasing his contributions to both the medical and financial sectors. His innovative work has made significant impacts in treating bacterial infections and enhancing financial trading strategies.
Latest Patents
One of Spector's latest patents is for pediatric oral suspension formulations of amoxicillin and clavulanate potassium. This invention is directed towards a composition that contains amoxicillin and clavulanate potassium, where the clavulanate potassium is present in an amount equal to or less than about 21.5 mg/5 mL. The method described in this patent aims to treat bacterial infections by providing between about one to about fourteen dosage days of the composition. Another significant patent is for an arbitrage of tracking securities. This financial product is based on a first fund traded in a first country, which has characteristics based on an index of securities traded in a second, different country. The first fund is designed to be arbitragable with a second fund based on the same index, enhancing trading opportunities across borders.
Career Highlights
Throughout his career, Michael S Spector has worked with prominent companies such as Nasdaq OMX Group, Inc. and Nasdaq Stock Market, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, particularly in the fields of finance and pharmaceuticals.
Collaborations
Spector has collaborated with notable professionals in his field, including Steven M Bloom and John L Jacobs. These partnerships have contributed to the development of his patents and innovations.
Conclusion
Michael S Spector's contributions to the fields of pharmaceuticals and financial products highlight his innovative spirit and dedication to improving health and financial systems. His patents reflect a blend of scientific and financial expertise that continues to influence these industries.